ãªãžã§ããã³ã»ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºç€Ÿã¯ãäžçäžã®ããŸããŸãªç
ç¶ãæ²»çããããã®å»è¬åã®çºèŠãçºæãéçºã補é ãããã³åååãè¡ã£ãŠããŸããå瀟ã®è£œåã«ã¯ã滲åºåå éœ¢é»æå€æ§çããã³ç³å°¿ç
é»ææµ®è
«ãè¿èŠæ§èçµ¡èæ°çè¡ç®¡ãç³å°¿ç
ç¶²èçãç¶²èéèéå¡çã«äŒŽãé»ææµ®è
«ïŒç¶²èäžå¿éèéå¡çã«äŒŽãé»ææµ®è
«ããã³ç¶²èéèåæéå¡çã«äŒŽãé»ææµ®è
«ãå«ãïŒã®æ²»çã®ããã® EYLEA 泚å°å€ããããŸãããŸããæäººã®ã¢ãããŒæ§ç®èçããã³åæ¯ã®æ²»çã®ããã® Dupixent 泚å°å€ãæäººã®ãããæ¥åæ§å®¶ææ§é«ã³ã¬ã¹ãããŒã«è¡çãŸãã¯èšåºçåèç¡¬åæ§å¿è¡ç®¡çŸæ£ã®æ²»çã®ããã® Praluent 泚å°å€ãæäººã®é¢ç¯ãªãŠããã®æ²»çã®ããã®ç®äžæ³šå°çš Kevzara 溶液ãæäŸããŠããŸããããã«ãå瀟ã¯è»¢ç§»æ§ãŸãã¯å±æé²è¡æ§ç®èæå¹³äžç®ããã®æ²»çè¬ Libtayo 泚å°å€ãå®¶ææ§å¯å·èªå·±çççå矀ãããã¯ã«ã»ãŠã§ã«ãºçå矀ãªã©ã®ã¯ãªãªããªã³é¢é£åšææ§çåçŸ€ã®æ²»çè¬ ARCALYST 泚å°å€ã転移æ§å€§è
žããã®æ²»çè¬ ZALTRAP ç¹æ»Žé泚å€ãæäŸããŠãããããã«ãã¶ã€ãŒã«ãšãã©ãŠã€ã«ã¹ææçã®æ²»çè¬ Inmazeb 泚å°å€ãæäŸããŠãããçŒçŸæ£ãã¢ã¬ã«ã®ãŒã»ççæ§çŸæ£ããããå¿è¡ç®¡ã»ä»£è¬æ§çŸæ£ãçŒççŸæ£ãææçãªã©ã®çŸæ£ãæ£ãæ£è
ã®æ²»çè¬åè£ã®éçºãè¡ã£ãŠãããå瀟ã¯ããµããã£ããã€ãšã«ããã補è¬ãäžè±ç°èŸºè£œè¬ãã¢ã«ãã€ã©ã ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºããã·ã¥ ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºãããã¯ãµ ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºãšææºããã³ã©ã€ã»ã³ã¹å¥çŽãçµãã§ããã»ããç±³åœä¿å¥çŠç¥çãšãå¥çŽãçµãã§ãããå瀟ã¯ãZai Lab LimitedãIntellia TherapeuticsãInc.ãçç©å»åŠå
端ç ç©¶éçºå±ãããã³ AstraZeneca PLC ã§ããRegeneron Pharmaceuticals, Inc. 㯠1988 幎ã«èšç«ããããã¥ãŒãšãŒã¯å·ã¿ãªãŒã¿ãŠã³ã«æ¬ç€Ÿã眮ããŠããŸãã